Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

HebaBiz Biotech’s anti-cancer drug candidate under development Siroquine (JP001) has been approved for IND clinical trials in the United States,

HebaBiz Biotech is pleased to announce, it has come to its knowledge on August 16, 2021, that the U.S. Food and Drug Administration (FDA) had granted clinical …, HebaBiz Biotech is pleased to announce, it has come to its knowledge on August 16, 2021, that the U.S. Food and Drug Administration (FDA) had granted clinical …, Read More

Scroll to Top